Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring

View source ↗

Summary

A Bristol-Myers Squibb-sponsored clinical trial is evaluating the safety of ozanimod exposure during pregnancy and in offspring among individuals with multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Multiple Sclerosis | Status: RECRUITING